2nd Quarter - Report

PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 18, 2017 $50,000 Replaced
2nd Quarter - Amendment Dec 14, 2017 $120,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.

Foreign entity interest: GRIFOLS S.A.

LobbyistCovered position, as disclosed
JULIE BIRKOFER —
THOMAS B LILBURN —
BRENNA RAINES —
KIMBERLY SEROTA —
CHASE THOMAS —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 34 (115th), H.R. 1628 (115th)

Health Issues HCR

HR 1600 and HR 2999, Patients' Access to Treatments Act of 2017, pertaining to specialty insurance tiers. The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.

Foreign entity interest: GRIFOLS S.A.

LobbyistCovered position, as disclosed
JULIE BIRKOFER —
THOMAS B LILBURN —
BRENNA RAINES —
KIMBERLY SEROTA —
CHASE THOMAS —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1628 (115th), H.R. 1600 (115th), H.R. 34 (115th), H.R. 2999 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.